1Socialstyrelsen. Nationell utvärdering 2013 – Vård och Insatser vid Depression, Ångest och Schizofreni Rekommendationer, Bedömningar och Sammanfattning [The National Board of Health and Welfare. National evaluation, 2013 – care and interventions for depression, anxiety and schizophrenia, recommendations, estimates and summary]. Socialstyrelsen, 2013.
2Morgan, D. Mindfulness-based cognitive therapy for depression: a new approach to preventing relapse. Psychother Res 2003; 13: 123–5.
3Sundquist, J, Lilja, A, Palmer, K, Memon, AA, Wang, X, Johansson, LM, et al. Mindfulness group therapy in primary care patients with depression, anxiety and stress and adjustment disorders: randomised controlled trial. Br J Psychiatry 2015; 206: 128–35.
4Sundquist, J, Palmer, K, Johansson, LM, Sundquist, K. The effect of mindfulness group therapy on a broad range of psychiatric symptoms: a randomised controlled trial in primary health care. Eur Psychiatry 2017; 43: 19–27.
5Kuyken, W, Hayes, R, Barrett, B, Byng, R, Dalgleish, T, Kessler, D, et al. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study). Health Technol Assess 2015; 19: 1–124.
6Morriss, R, Garland, A, Nixon, N, Guo, B, James, M, Kaylor-Hughes, C, et al. Efficacy and cost-effectiveness of a specialist depression service versus usual specialist mental health care to manage persistent depression: a randomised controlled trial. Lancet Psychiatry 2016; 3: 821–31.
7Shawyer, F, Enticott, JC, Ozmen, M, Inder, B, Meadows, GN. Mindfulness-based cognitive therapy for recurrent major depression: a ‘best buy’ for health care? Aust N Z J Psychiatry 2016; 50: 1001–13.
8Kabat-Zinn, J, Lipworth, L, Burncy, R, Sellers, W. Four-year follow-up of a meditation-based program for the self-regulation of chronic pain: treatment outcomes and compliance. Clin J Pain 1986; 2: 159–774.
9Kabat-Zinn, J, Massion, AO, Kristeller, J, Peterson, LG, Fletcher, KE, Pbert, L, et al. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am J Psychiatry 1992; 149: 936–43.
10Herdman, M, Gudex, C, Lloyd, A, Janssen, M, Kind, P, Parkin, D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011; 20(10): 1727–36.
11Devlin, NJ, Shah, KK, Feng, Y, Mulhern, B, van Hout, B. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ 2018; 27: 7–22.
12Manca, A, Hawkins, N, Sculpher, MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 2005; 14: 487–96.
13Drummond, MF, Sculpher, MJ, Torrance, GW, O'Brien, BJ, Stoddart, GL. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press, 2005.
16Weisbrod, BA. The valuation of human capital. J Polit Econ 1961; 69: 425–36.
18Briggs, AH, Wonderling, DE, Mooney, CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997; 6: 327–40.
19Efron, B, Tibshirani, RJ. An Introduction to the Bootstrap. CRC Press, 1994.
20Briggs, A, Fenn, P. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Econ 1998; 7: 723–40.
21Fenwick, E, O'Brien, BJ, Briggs, A. Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions. Health Econ 2004; 13: 405–15.
22National Institute for Health and Care Excellence. Guide to the Methods of Technology Appraisal. NICE, 2004.
23Husereau, D, Drummond, M, Petrou, S, Carswell, C, Moher, D, Greenberg, D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Br Med J 2013; 346; f1049.
24Lavori, PW, Dawson, R, Shera, D. A multiple imputation strategy for clinical trials with truncation of patient data. Statist Med 1995; 14: 1913–25.
25Rubin, D. Multiple Imputation for Nonresponse in Surveys. Wiley & Sons, 1987.
26Frew, E. Applied Methods of Cost-Benefit Analysis in Health Care. Oxford University Press, 2010.
27Lejtzen, N, Sundquist, J, Sundquist, K, Li, X. Depression and anxiety in Swedish primary health care: prevalence, incidence, and risk factors. Eur Arch Psychiatry Clin Neurosci 2014; 264: 235–45.
28Piet, J, Hougaard, E. The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis. Clin Psychol Rev 2011; 31: 1032–40.
29Edwards, RT, Bryning, L, Crane, R. Design of economic evaluations of mindfulness-based interventions: ten methodological questions of which to be mindful. Mindfulness 2015; 6: 490–500.
30Briggs, A. Economic evaluation and clinical trials: size matters. BMJ 2000; 321: 1362–3.